hydroxychloroquine plus macrolides - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 mild to moderate

	COVID 19 hospitalized	COVID-19 mild to moderate
hydroxychloroquine plus macrolides
azithromycin plus hydroxychloroquine	ProPAC-COVID	Coalition Covid-19 Brazil I ...

10 studies excluded by filtering options 0

5314	Magagnoli (HC AZ), 2020	1	13	3		not a RCT	high risk of bias
5365	Rosenberg, 2020	1	13	3		not a RCT	high risk of bias
5371	Carlucci, 2020	0	13	4	selection pending
5375	Mehra, 2020	2	13	3	excluded	not a RCT	high risk of bias
5482	Sbidian (HCQ plus AZI), 2020	1	13	4		not a RCT	high risk of bias
5509	Lagier, 2020	1	13	4		not a RCT	high risk of bias
5513	Arshad (HCQ AZ), 2020	1	13	4		not a RCT	high risk of bias
5559	Davido, 2020	1	13	4		not a RCT	high risk of bias
5987	Duke university HCQ-AZI, 2020	1	1	0			risk of bias not avaialble
6034	Huang, 2020	0	99	0	selection pending